Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats
Hepatocellular carcinoma is one of the most common cancers, and approximately 80% develop from cirrhotic livers. We have previously shown that the aspartate salt of adenosine prevents and reverses carbon tetrachloride-induced liver fibrosis in rats. Considering the hepatoprotective role of this aden...
| Author: | |
|---|---|
| Format: | Article |
| Status: | Published version |
| Publication date: | 2017 |
| Country: | México |
| Institution: | INMIGEN |
| Repository: | Repositorio del Instituto Nacional de Medicina Genómica |
| OAI Identifier: | oai:repositorio.inmegen.gob.mx:14 |
| Online Access: | http://repositorio.inmegen.gob.mx/record/14 |
| Access Level: | Open access |
| Keyword: | info:eu-repo/classification/cti/3 |
| _version_ | 1878408361325625344 |
|---|---|
| author | JULIO ISAEL PÉREZ CARREÓN |
| author_browse | JULIO ISAEL PÉREZ CARREÓN |
| author_facet | JULIO ISAEL PÉREZ CARREÓN |
| author_role | author |
| collection | Repositorio del Instituto Nacional de Medicina Genómica |
| description | Hepatocellular carcinoma is one of the most common cancers, and approximately 80% develop from cirrhotic livers. We have previously shown that the aspartate salt of adenosine prevents and reverses carbon tetrachloride-induced liver fibrosis in rats. Considering the hepatoprotective role of this adenosine derivative in fibrogenesis, we were interested in evaluating its effect in a hepatocarcinogenesis model induced by diethylnitrosamine in rats, where multinodular cancer is preceded by cirrhosis. Rats were injected with diethylnitrosamine for 12 weeks to induce cirrhosis and for 16 weeks to induce hepatocarcinogenesis. Groups of rats were treated with aspartate salt of adenosine from the beginning of carcinogen administration for 12 or 18 weeks total, and another group received the compound from weeks 12 to 18. Fibrogenesis was estimated and the proportion of preneoplastic nodules and tumors was measured. The apoptotic and proliferation rates in liver tissues were evaluated, as well as the expression of cell signaling and cell cycle proteins participating in hepatocarcinogenesis. The adenosine derivative treatment reduced diethylnitrosamine-induced collagen expression and decreased the proportion of nodules positive for the tumor marker gamma-glutamyl transferase. This compound down-regulated the expression of thymidylate synthase and hepatocyte growth factor, and augmented the protein level of the cell cycle inhibitor p27; these effects could be part of its chemopreventive mechanism. These findings suggest a hepatoprotective role of aspartate salt of adenosine that could be used as a therapeutic compound in the prevention of liver tumorigenesis as described earlier for hepatic fibrosis. |
| eu_rights_str_mv | openAccess |
| format | article |
| id | MX_4e32a96bc9ceed13a331ca2ce87d3b46 |
| institution | INMIGEN |
| instname_str | Instituto Nacional de Medicina Genómica |
| network_acronym_str | MX |
| network_name_str | México |
| oai_identifier_str | oai:repositorio.inmegen.gob.mx:14 |
| publishDate | 2017 |
| publishDateSort | 2017 |
| publisher | TUMOR BIOLOGY |
| publisherStr | TUMOR BIOLOGY |
| reponame_str | Repositorio del Instituto Nacional de Medicina Genómica |
| spelling | Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats JULIO ISAEL PÉREZ CARREÓN info:eu-repo/classification/cti/3 Hepatocellular carcinoma is one of the most common cancers, and approximately 80% develop from cirrhotic livers. We have previously shown that the aspartate salt of adenosine prevents and reverses carbon tetrachloride-induced liver fibrosis in rats. Considering the hepatoprotective role of this adenosine derivative in fibrogenesis, we were interested in evaluating its effect in a hepatocarcinogenesis model induced by diethylnitrosamine in rats, where multinodular cancer is preceded by cirrhosis. Rats were injected with diethylnitrosamine for 12 weeks to induce cirrhosis and for 16 weeks to induce hepatocarcinogenesis. Groups of rats were treated with aspartate salt of adenosine from the beginning of carcinogen administration for 12 or 18 weeks total, and another group received the compound from weeks 12 to 18. Fibrogenesis was estimated and the proportion of preneoplastic nodules and tumors was measured. The apoptotic and proliferation rates in liver tissues were evaluated, as well as the expression of cell signaling and cell cycle proteins participating in hepatocarcinogenesis. The adenosine derivative treatment reduced diethylnitrosamine-induced collagen expression and decreased the proportion of nodules positive for the tumor marker gamma-glutamyl transferase. This compound down-regulated the expression of thymidylate synthase and hepatocyte growth factor, and augmented the protein level of the cell cycle inhibitor p27; these effects could be part of its chemopreventive mechanism. These findings suggest a hepatoprotective role of aspartate salt of adenosine that could be used as a therapeutic compound in the prevention of liver tumorigenesis as described earlier for hepatic fibrosis. TUMOR BIOLOGY http://repositorio.inmegen.gob.mx/record/14 |
| spellingShingle | Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats JULIO ISAEL PÉREZ CARREÓN info:eu-repo/classification/cti/3 |
| status_str | publishedVersion |
| title | Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats |
| title_full | Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats |
| title_fullStr | Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats |
| title_full_unstemmed | Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats |
| title_short | Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats |
| title_sort | Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats |
| topic | info:eu-repo/classification/cti/3 |
| topic_facet | info:eu-repo/classification/cti/3 |
| url | http://repositorio.inmegen.gob.mx/record/14 |